The phosphatidyl inositol 3-kinase pathway is central to the pathogenesis of Kit-activated melanoma
Article first published online: 10 JUN 2011
© 2011 John Wiley & Sons A/S
Pigment Cell & Melanoma Research
Volume 24, Issue 4, pages 714–723, August 2011
How to Cite
Liang, R., Wallace, A. R., Schadendorf, D. and Rubin, B. P. (2011), The phosphatidyl inositol 3-kinase pathway is central to the pathogenesis of Kit-activated melanoma. Pigment Cell & Melanoma Research, 24: 714–723. doi: 10.1111/j.1755-148X.2011.00870.x
- Issue published online: 18 AUG 2011
- Article first published online: 10 JUN 2011
- Accepted manuscript online: 19 MAY 2011 10:42AM EST
- PUBLICATION DATA Received 28 March 2011, revised and accepted for publication 18 May 2011, published online 19 May 2011
Figure S1. Ras G12V cells are not sensitive to Kit inhibition.
Table S1. Primers for site-directed mutagenesis of mouse Kit gene.
|PCMR_870_sm_apps1.pdf||1346K||Supporting info item|
|PCMR_870_sm_tabs1.pdf||218K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.